www.HIVdent.org

 

ABSTRACT PLENARY LECTURES P1 - Global and Regional Epidemiology of HIV and Its Implications P2 - HIV/AIDS Status and Trends in Asia and the Pacific Region P3 - Impact and Management of HIV in Thailand and South East Asia P3A - HIV Care and Counseling in India P3B - Action Programme Towards Control of HIV/AIDS: the Role of the WHO Global Oral Health Programme, Geneva, Switzerland P4 - HIV Pathogenesis: Knowledge Gained after Two Decades of Research P5 - Therapeutic Management of HIV P6 - Innate and Adaptive Mucosal Immunity in Protection Against HIV Infection P8 - Oral Lesions of HIV/AIDS in Industrialized Countries P9 - Oral Lesions and Conditions Associated with Human Immunodeficiency Virus Infection in 1700 South Indian Patients P10 - Public Health Implications of Oral Disease in HIV/AIDS P11 - Molecular Mechanism of Salivary Gland Disease (SGD) P12 - Dendritic Cells and HIV Infection P13 - Epithelial Cells in HIV Infection P14 - Expression of HIV-1 Receptors, Co-receptors and Alpha-defensins P14A - Current Status of Oral Mucosal Immunity in HIV P15 - Skin Lesions: Mirror Images of Oral Lesion Infections P16 - Prevention and Treatment of Opportunistic Infections Associated with HIV in Thailand P17 - Candida Host Interactions in HIV P18 - Lipid-Mediated Dialogues Between Host and Pathogen P19 - Viruses in the Oral Cavity in HIV Disease: An Overview P20 - Expression and Oral Manifestation of EBV and HHV8 P21 - Biology of HPV in HIV Infection ABSTRACT Plenary Workshop W1 - Scientific Opportunities and Mechanisms from the NIDCR/NIH W2 - Research and Training Opportunities from the NIDCR/NIH W3 - Role of the WHO W4 - Collaborative Research and Funding Mechanisms ABSTRACT Posters CLINICAL ORAL LESIONS AND MANAGEMENT OF HIV RELATED DISEASE A1 - Oral Manifestations of HIV in Pregnant Women Attending Antenatal Clinics in Johannesburg A2 - Common Oral Lesions Seen Amongst Sero-positive Clients at a Voluntary Confidential Counseling Testing Centre in Kaduna Nigeria A3 - Gender Differences in Oral Manifestations Among South African HIV/AIDS Patients A4 - HIV Related Oral Diseases Among Women in Zimbabwe A5 - Oro-facial Manifestations in Paediatric HIV: A Comparative Study of Institutionalized and Hospital Out-Patients A6 - Oral Manifestation of HIV Pediatric Cases in Chennai, South India A7 - Classification of Oral Diseases of HIV-Associated Immune Suppression A8 - Smoking as a Predictor of Oral Manifestation of HIV Infection HEALTH CARE NEEDS A12 - Oral and Maxillofacial Surgery for the Seropositive Patient in a Resource Limited Setting A13 - Awareness of Occupational Exposure to HIV Infection Among Dental Surgeons in Chennai, South India- Study of Knowledge, Attitudes and Behaviour (KAB) A14 - Concerns Reported to Dental Protection Limited by Dental Healthcare Workers Treating HIV Positive Patients: 1985-2002 A15 - Formulation of India-specific Protocols for Oral Aspects of HIV Care Research and Education A16 - Association Between Self Risk Perception of Occupational HIV Infection and Hollow Needle Stick Injuries Amongst Kenyan Oral Health Practitioners A17 - Cost of In-Patient Care for HIV-Positive Paediatric Patients at Red Cross Children's Hospital, Cape Town, South Africa

ORAL HEALTH AND GENERAL HEALTH A9 - The Association of Peripheral Blood Abnormalities and HIV-Associated Oral Lesions A10 - Salivary and Oral Findings in HIV-positive and HIV-Negative Subjects with Well-Controlled Medication A11 - Quality of Life and Oral Mucosal Lesions Among HIV-Positive Drug Addicts CLINICAL / BASIC SCIENCE CANDIDA AND MYCOTIC INFECTIONS A18 - Assessment of Association Between Viral Load CD4 Count and Occurrence of Oropharangeal Candidiasis in HIV+ Patients A19 - Chlorhexidine Mouth-Rinse in Maintenance of Oral Candidiasis-Free Period Among HIV-Infected Subjects: An Intervention Study A20 - Typing and Clinical Relevance of Candida albicans in HIV-Infected Patients A21 - The Frequencies and Biological Properties of Candida albicans and C. dubliniensis from HIV-Positive and -Negative Japanese A22 - In vitro Antifungal Activity of Dodonaea angustifolia, a Traditional South African Medicinal Plant A23 - Antifungal Activity of Potassium Lawsone Methyl Ether Mouthwash in Comparison with Chlorhexidine Mouthwash on Oral Candida Isolated from HIV/AIDS Subjects A24 - A Longitudinal Evaluation of Oropharyngeal Candidiasis in a Cohort of HIV Positive Patients Attending a Dedicated Clinic in New Orleans PERIODONTAL DISEASE AND GINGIVITIS A25 - The Burden of Necrotising Ulcerative Gingivitis and Periodontitis Among Adult Patients Attending a Sexually Transmitted Infection Clinic in Johannesburg A26 - Oral and Periodontal Lesions in 1700 HIV Positive Patients in South India HAART THERAPY AND ORAL LESIONS A27 - The Changing Face of Oral Lesions in HIV/AIDS Patients Undergoing Highly Active Antiretroviral Treatment BASIC SCIENCE VIRUSES: INTERACTION AND EXPRESSION IN HIV DISEASE A28 - Human Papillomavirus (HPV) Type 32 Specific Serum IgG Response in HIV-Infected Adults A29 - Local Immune Reactivity in Oral Warts and Oral Hairy Leukoplakia of HIV-infected Persons A30 - Detailed History of HIV+ Individuals with Oral Warts Reveals the Possibility of Two Epidemics A31 - Site-Specific Prevalence of 27 Human Papillomavirus (HPV) Genotypes in the Oral Cavity of HIV+ Individuals A32 - Cytomegalovirus Co-Infection in AIDS Associated Oral Kaposi’s Sarcoma     SALIVA, BREAST MILK AND MUCOSAL FLUIDS IN HIV TRANSMISSION A33 - HIV Antibody Screening; Saliva an Alternative to Serum A34 - A Study of Salivary Flow Rate, Subjective Symptoms of Dry Mouth and Secretory IgA Levels in HIV Seropositive Patients in Chennai, South India A35 - Elevation of Salivary Antimicrobial Protein Concentrations Against Increase of Candida Depending on CD4+ Count in HIV-Positives A36 - Identifying Viral Characteristics Responsible for Oral Transmission of SIV Through Breast Milk in Rhesus Monkeys A36-1 - Immunoglobulin A (IgA) Levels in the Oral Cavity and Respiratory Tract of HIV+ Individuals Treated with Highly Active Antiretroviral Therapy (HAAR)     EPITHELIAL AND NON-SPECIFIC HOST FACTORS A37 - HIV-1 and C. albicans Regulate Expression of Calprotectin (S100A8/A9) in Tonsillar Epithelial Cells A38 - Innate Host Defense in Oral Mucosal Resistance to HIV-1 A39 - Permissive Factors Underlying HIV-1 Infection in the Tonsil A40 - Oral Epithelial Cell Anti-Candida Activity – Evidence Against a Presumtive Role for Carbohydrate